More EchoIQ Limited news
EchoIQ LimitedASX: EIQ

Echo IQ Commences New Heart Failure Clinical Study Using AI

May 20, 2024 at 10:39 PM EDT · Issued by EchoIQ Limited

Filed with ASX · May 20, 2024 at 10:39 PM EDT

On 6ix: 6ix.com/news/echo-iq-commences-new-heart-failure-clinical-study-using-ai

Echoiq Limited has released a press release.

View Attachment

6ix hasn’t read this filing yet.

EchoIQ Limited on 6ix

In the deck

  • Echoiq — Investor Presentation (May 2024)21 slidesMay 23, 2024

Earlier from EchoIQ

  • US FDA Application LodgedMay 6, 2024
  • Quarterly ReportApr 30, 2024
  • Appendix 4C Cash Flow ReportApr 30, 2024
  • Management UpdateApr 1, 2024
  • Completion of US Reader StudyMar 27, 2024

Later from EchoIQ

  • Investor PresentationMay 22, 2024
  • Validation of EIQ AI at Leading Scientific ConferenceJun 5, 2024
  • Strategic Integration Partnership Agreement with ScImage IncJul 4, 2024
  • Groundbreaking study results for Heart Failure AI solutionSep 3, 2024
  • Echo IQ Raises $7.1 millionSep 6, 2024
All EchoIQ news releases↗

Follow EchoIQ into a list and get an email when it puts out news.

Follow EchoIQ
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer